Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer

@inproceedings{Ichikawa2016ImpactOI,
  title={Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer},
  author={Wataru Ichikawa and Masanori Terashima and Atsushi Ochiai and Koji Kitada and Issei Kurahashi and Shinichi Sakuramoto and Hitoshi Katai and Takeshi Sano and Hiroshi Imamura and Mitsuru Sasako},
  booktitle={Gastric Cancer},
  year={2016}
}
Exploratory biomarker analysis was conducted to identify factors related to the outcomes of patients with stage II/III gastric cancer using data from the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer, which was a randomized controlled study comparing the administration of an orally active combination of tegafur, gimeracil, and oteracil with surgery… CONTINUE READING